<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=412980&amp;fmt=gif">
Longevity Logo

21-22 April 2020
London, UK
 

Advisory Board and Key Speakers

The Science Of Ageing And Age-Related Disease

James Peyer, CEO, Apollo Ventures
James Peyer
CEO
Apollo Ventures
Aubrey de Grey, CSO, SENS Research Foundation and VP, AgeX Therapeutics
Aubrey de Grey
CSO, SENS Research Foundation;
VP, AgeX Therapeutics
Tristan Edward, CEO, Life Biosciences
Tristan Edwards
CEO
Life Biosciences
Sree Kant, Head of Business Development, Life Biosciences
Sree Kant
Head of Business Development
Life Biosciences
Sergey Young, Founder, Longevity Vision Fund
Sergey Young
Founder
Longevity Vision Fund
Lynne Cox, Associate Professor, University of Oxford
Lynne Cox
Associate Professor
University of Oxford
Joao Pedro de Magalhaes, Scientist and Futurist, University of Liverpool
Joao Pedro de Magalhaes
Scientist and Futurist
University of Liverpool
Mark Allen, CEO, Elevian
Mark Allen
CEO
Elevian

Age-Tech And Risk

John Godfrey, Head of Corporate Affairs, Legal and General
John Godfrey
Head of Corporate Affairs
Legal and General
Wilf Blackburn, CEO, Prudential Singapore
Wilf Blackburn
CEO
Prudential Singapore
Steven Baxter, Head of Longevity Research, Hymans
Steven Baxter
Head of Longevity Research
Hymans
Dominic Endicott, CEO, 4Gen Ventures
Dominic Endicott
CEO
4Gen Ventures
Tina Woods, CEO, Collider Health
Tina Woods
CEO
Collider Health
Paul Gaudin, CEO, CareRooms
Paul Gaudin
CEO
CareRooms
Andrew Fried, Life Sciences Global Industry Leader, IBM
Andrew Fried
Life Sciences Global Industry Leader
IBM
Joe Tighe, Head of Strategy, Benevolent AI
Joe Tighe
Head of Strategy
Benevolent AI
DOWNLOAD BROCHURE

Never Miss An Update

Sign up to event updates to hear about new speakers, promotions, congress news and networking events.